Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Adult Attention Deficit Hyperactivity Disorder

ClinicalTrials.gov ID: NCT01692782

Public ClinicalTrials.gov record NCT01692782. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 1:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2 study of SEP-225289 in adults with attention deficit hyperactivity disorder (ADHD).

Study identification

NCT ID
NCT01692782
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
341 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2012
Primary completion
Oct 31, 2013
Completion
Nov 30, 2013
Last update posted
Jan 11, 2015

2012 – 2013

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Pharmacology Research Institute Encino California 91316
Collaborative Neuroscience Network Inc Garden Grove California 92645
University of California at Irvine Irvine California 92612
Pharmacology Research Institute Los Alamitos California 90720
Pharmacology Research Institute Newport Beach California 92660-2452
Excell Research, Inc Oceanside California 92056
Neuropsychiatric Research Center of Orange County Santa Ana California 92701
Florida Clinical Research Center, LLC Bradenton Florida 34201
Clinical Neuroscience Solutions Inc. Jacksonville Florida 32216
Florida Research Center Maitland Florida 32751
Miami Research Associates Miami Florida 33143
Research Centers of America, LLC Oakland Park Florida 33334
Medical Research Group of Central Florida Sanford Florida 32771
Atlanta Center for Medical Research Atlanta Georgia 30308
iResearch Atlanta, LLC Decatur Georgia 30030
Goldpoint Clinical Research Indianapolis Indiana 46260
IPS Research Company Oklahoma City Indiana 73103
Rochester Center for Behavioral Health Rochester Hills Michigan 48307
Midwest Research Group Saint Charles Missouri 63301
Center for Emotional Fitness Cherry Hill New Jersey 08002
Brooklyn Medical Institutes, LLC Brooklyn New York 11214
Duke Child and Family Study Center Durham North Carolina 27705
Midwest Clinical Research Center Dayton Ohio 45408
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97210
Suburban Research Associates Media Pennsylvania 19063
CRI Lifetree Philadelphia Pennsylvania 19139
Clinical Neuroscience Solutions Memphis Tennessee 38119
Future Search Clinical Trials, LP Austine Texas 78731
NeuroScience, Inc Herndon Virginia 20170
Eastside Therapeutic Resource Kirkland Washington 98033
Summit Research Network, LLC-Seattle Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01692782, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2015 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01692782 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →